Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study.

Trial Profile

Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs Efavirenz; Nevirapine
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms SIROCCO
  • Most Recent Events

    • 16 Oct 2008 Status changed from discontinued to completed, as reported by ClinicalTrials.gov.
    • 26 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top